Scholarlink

Background <p>Kidney dysfunction is common in patients with advanced heart failure and is associated with adverse clinical outcomes. Left ventricular assist device (LVAD) implantation may influence renal function through hemodynamic and cardiorenal changes. We performed a meta-analysis to evaluate longitudinal changes in estimated glomerular filtration rate (eGFR) following LVAD implantation.</p> Results <p>We systematically searched six databases for studies reporting eGFR before and after LVAD implantation until March 2026. The primary analysis used a multivariate random-effects meta-analysis to jointly pool repeated follow-up estimates while accounting for within-study dependence across time points. Pooled mean changes in eGFR and 95% confidence intervals (CIs) were estimated at 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months, 1 year, 2 years, and 3 years after implantation. A total of 38 studies contributing 95 effect sizes were included. Compared with baseline, pooled mean eGFR was significantly higher at 1 week (18.83 mL/min/1.73&#xa0;m²; 95% CI: 13.21, 24.46), 2 weeks (18.29; 95% CI: 12.11, 24.48), 1 month (23.77; 95% CI, 19.48, 28.07), 3 months (15.20; 95% CI: 10.95, 19.46), 6 months (7.97; 95% CI: 3.72, 12.22), 9 months (8.27; 95% CI: 2.10, 14.44), and 1 year (7.34; 95% CI: 2.83, 11.85), but not at 2 or 3 years. In subgroup analyses, studies with baseline eGFR &lt; 60 mL/min/1.73&#xa0;m² showed significant increases across all evaluated follow-up intervals, whereas those with baseline eGFR ≥ 60 mL/min/1.73&#xa0;m² showed significant increases only through 3 months.</p> Conclusions <p>LVAD implantation was associated with higher eGFR during the early postoperative period, with the largest increase observed at 1 month. However, because most included studies were pre-post analyses without non-LVAD comparator groups, these findings should be interpreted cautiously and do not establish a causal effect. Future research should explore the long-term impact of LVAD on renal health to optimize care strategies and outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The impact of left ventricular assist devices on kidney function: a systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月26日

查看全文
  • Alireza Hosseini,
  • Bahar Darouei,
  • Reza Amani-Beni,
  • Davood Shafie,
  • Sadegh Mazaheri-Tehrani,
  • Mohammad Ali Haghighatpanah,
  • Maryam Heidarpour,
  • Ehsan Amini-Salehi,
  • Seyyed Mohammad Hashemi,
  • Anil Harrison,
  • Irbaz Hameed,
  • Christopher M. Reid,
  • Mohammad Reza Movahed

摘要

Background

Kidney dysfunction is common in patients with advanced heart failure and is associated with adverse clinical outcomes. Left ventricular assist device (LVAD) implantation may influence renal function through hemodynamic and cardiorenal changes. We performed a meta-analysis to evaluate longitudinal changes in estimated glomerular filtration rate (eGFR) following LVAD implantation.

Results

We systematically searched six databases for studies reporting eGFR before and after LVAD implantation until March 2026. The primary analysis used a multivariate random-effects meta-analysis to jointly pool repeated follow-up estimates while accounting for within-study dependence across time points. Pooled mean changes in eGFR and 95% confidence intervals (CIs) were estimated at 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months, 1 year, 2 years, and 3 years after implantation. A total of 38 studies contributing 95 effect sizes were included. Compared with baseline, pooled mean eGFR was significantly higher at 1 week (18.83 mL/min/1.73 m²; 95% CI: 13.21, 24.46), 2 weeks (18.29; 95% CI: 12.11, 24.48), 1 month (23.77; 95% CI, 19.48, 28.07), 3 months (15.20; 95% CI: 10.95, 19.46), 6 months (7.97; 95% CI: 3.72, 12.22), 9 months (8.27; 95% CI: 2.10, 14.44), and 1 year (7.34; 95% CI: 2.83, 11.85), but not at 2 or 3 years. In subgroup analyses, studies with baseline eGFR < 60 mL/min/1.73 m² showed significant increases across all evaluated follow-up intervals, whereas those with baseline eGFR ≥ 60 mL/min/1.73 m² showed significant increases only through 3 months.

Conclusions

LVAD implantation was associated with higher eGFR during the early postoperative period, with the largest increase observed at 1 month. However, because most included studies were pre-post analyses without non-LVAD comparator groups, these findings should be interpreted cautiously and do not establish a causal effect. Future research should explore the long-term impact of LVAD on renal health to optimize care strategies and outcomes.